Skip to content
BC

Boston Commerce

531458 BSE
₹11.50

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹11.50 +3.38 +41.6% 1Y
Start ₹8.12

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
−112.00%
Debt to Equity
Not meaningful: shareholders’ equity is negative
EPS (TTM)
−₹0.82
Book Value
−₹1.82
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
Not meaningful: book value is negative
ROE
Not meaningful: shareholders’ equity is negative
Dividend Yield
0.00%
EBITDA
−₹6.60 Cr
52W High
₹11.58
52W Low
₹4.01

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

59 Good

Data confidence 86/100

Category scores

Quality
57
Good
Returns, margins, earnings quality 22% weight
Valuation
50
Average
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
17
Poor
Solvency, leverage, coverage 9% weight
Momentum
98
Strong
Trend strength, vol-adjusted 12% weight
Ownership
58
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding is low: 2.14%
  • Company has a low return on equity of -52.4% over last 3 years.
  • Company's cost of borrowing seems high

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish5212
OscillatorsStrong Bearish522
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
76.47
Bearish
MACD (12,26,9)
0.87
Bearish
SMA (50)
8.05
Bullish
SMA (200)
7.02
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
10Y−10.77%
5YIrregular period
3YZero base
1Y+152.63%

Net profit

Net profit growth by window
10YTurned to loss
5YIrregular period
3YTurned to loss
1YLoss widened by ₹6.63 Cr

Operating cash flow

Operating cash flow growth by window
10YTurned positive
5YIrregular period
3YZero base
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
10YTiny sales
5YIrregular period
3YNo sales
1YTiny sales

Trailing twelve months: The last four quarters end with the latest fiscal year, which the 1Y column covers.

Revenue by year

Revenue by year, ₹ crore
Mar 2014₹0.05 Cr
Mar 2015₹0.06 Cr
Mar 2016₹1.50 Cr
Mar 2017₹0.53 Cr
Mar 2018₹0.70 Cr
Mar 2022₹0.00 Cr
Mar 2023₹0.00 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.19 Cr
Mar 2026₹0.48 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2014₹0.00 Cr
Mar 2015₹0.00 Cr
Mar 2016₹0.00 Cr
Mar 2017₹0.00 Cr
Mar 2018₹0.00 Cr
Mar 2022₹0.00 Cr
Mar 2023₹0.00 Cr
Mar 2024−₹0.14 Cr
Mar 2025−₹0.55 Cr
Mar 2026−₹7.18 Cr

Quarterly Results

₹ Cr

Results for the period ended Jun 2026 were due by 14 Aug 2026 and are not in this table yet.

531458 quarterly results, ₹ crore
Particulars Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
0
0
0
0
0
0
0
0
0.19
0.18
0.24
0.06
0
Expenses
0
0
0
0
0.14
0
0.01
0.05
0.68
0.1
0.14
0.04
0.08
Operating Profit
0
0
0
0
−0.14
0
−0.01
−0.05
−0.49
0.08
0.1
0.02
−0.08
OPM %
—
—
—
—
—
—
—
—
−257.89%
44.44%
41.67%
33.33%
—
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0.03
0.05
0.03
0.59
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
−0.14
0
−0.01
−0.05
−0.49
0.05
0.05
−0.01
−0.67
Tax %
—
—
—
—
0%
—
0%
0%
0%
20%
20%
0%
−4.48%
Net Profit
0
0
0
0
−0.14
0
−0.01
−0.05
−0.49
0.04
0.04
−0.01
−0.65
EPS (₹)
0
0
0
0
−0.2
0
−0.01
−0.07
−0.7
0.06
0.06
−0.01
−0.93

Profit & Loss

₹ Cr
531458 profit and loss, annual, ₹ crore
Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
0.12
0.15
0.05
0.06
1.5
0.53
0.7
0
0
0
0.19
0.48
Expenses
0.27
0.16
0.05
0.06
1.5
0.53
0.7
0
0
0.14
0.74
7.07
Operating Profit
−0.15
−0.01
0
0
0
0
0
0
0
−0.14
−0.55
−6.59
OPM %
−125%
−6.67%
0%
0%
0%
0%
0%
—
—
—
−289.47%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0.59
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
−0.15
−0.01
0
0
0
0
0
0
0
−0.14
−0.55
−7.18
Tax %
0%
0%
—
—
—
—
—
—
—
0%
0%
0%
Net Profit
−0.15
−0.01
0
0
0
0
0
0
0
−0.14
−0.55
−7.18
EPS (₹)
−0.21
−0.01
0
0
0
0
0
0
0
−0.2
−0.79
−10.25
Div. Payout %
0%
0%
—
—
—
—
—
—
—
0%
0%
0%

Balance Sheet

₹ Cr
531458 balance sheet, annual, ₹ crore
Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7
7
7
7
7
7
7
7
7
7
7
7
Reserves
−0.4
−0.4
−0.4
−0.4
−0.4
−0.4
−0.4
−0.41
−0.41
−0.55
−1.1
−8.27
Borrowings
0.14
0.12
0.12
0.12
0.87
0.87
0.87
0.87
0.87
0.87
5.44
1.66
Other Liabilities
0
−0.01
−0.01
−0.01
1.46
1.9
2.6
3.11
3.11
3.25
3.57
0.37
Total Liabilities
6.74
6.71
6.71
6.71
8.93
9.37
10.07
10.57
10.57
10.57
14.91
0.76
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
6.74
6.71
6.71
6.71
8.93
9.37
10.07
10.57
10.57
10.57
14.91
0.76
Total Assets
6.74
6.71
6.71
6.71
8.93
9.37
10.07
10.57
10.57
10.57
14.91
0.76

Cash Flow

₹ Cr
531458 cash flow, annual, ₹ crore
Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
0
0
0.97
−0.03
−0.02
0.13
0
0
0
−4.59
4.42
Investing
0
0
0
−0.91
0
0
−0.08
0
0
0
0
0
Financing
−1
0
0
0
0
0
0
0
0
0
4.58
−4.38
Net Cash Flow
0
0
0
0.06
−0.03
−0.02
0.05
0
0
0
−0.01
0.04
Free Cash Flow
1
0
0
0.97
−0.03
−0.02
0.13
0
0
0
−4.59
4.42
CFO/OP
−667
0
—
—
—
—
—
—
—
0
835
−67

Ratios

531458 financial ratios, annual
Particulars Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
0
0
363
1,343
1,309
—
—
—
5,533
0
Inventory Days
0
0
—
—
0
0
11.59
—
—
—
—
0
Days Payable
—
—
—
—
—
—
1,489
—
—
—
—
—
Cash Conversion Cycle
0
0
0
0
363
1,343
−169
—
—
—
5,533
0
Working Capital Days
−426
−292
−876
4,745
226
661
454
—
—
—
10,585
236
ROCE %
−2.05%
−0.15%
0%
0%
0%
0%
0%
—
0%
−1.89%
−5.89%
−112.36%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Boston Commerce insights

56 extracted metrics across FY00–FY26.

Shareholding Pattern

As of Sep 2026

  • Public 80.95%
  • Others 14.78%
  • Promoters 2.14%
  • DIIs 2.13%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Boston Commerce

What does Boston Commerce Limited do?
Incorporated in 1995, Boston Bio Systems Ltd is in the business of trading in goods e.g. Medical equipment, testing kits, instruments etc.
Where is Boston Commerce Limited (BOSTON) listed?
Boston Commerce Limited trades under code 531458 on the BSE.
Which sector does Boston Commerce Limited belong to?
Boston Commerce Limited is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the 52-week high and low of Boston Commerce Limited?
Over the last 52 weeks Boston Commerce Limited has traded between ₹4.01 and ₹11.58 as of 4 Nov 2026.

Company Information

Incorporated in 1995, Boston Bio Systems Ltd is in the business of trading in goods e.g. Medical equipment, testing kits, instruments etc.

Website bostonbiosystemltd.com
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531458.md for Boston Commerce Limited: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month